NewLeaf Symbiotics is an agtech company focused on developing sustainable agricultural products using bacteria and related microbes.
NewLeaf Symbiotics has raised $45.0M in total funding. The most recent round was Series D. The last funding was announced in December 2023.
NewLeaf Symbiotics's investors include S2G Investments, Pangaea Ventures, Lewis & Clark Ventures, Open Prairie, Leaps by Bayer.
NewLeaf Symbiotics is headquartered in St Louis, United States.
NewLeaf Symbiotics is an agtech company focused on developing sustainable agricultural products using bacteria and related microbes.
NewLeaf Symbiotics is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"NewLeaf Symbiotics — Funding & Investors." VCBacked, December 19, 2023, https://www.vcbacked.co/company/newleaf-symbiotics. Accessed July 20, 2026.
VCBacked. (2023). NewLeaf Symbiotics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/newleaf-symbiotics
{{cite web |title=NewLeaf Symbiotics — Funding & Investors |url=https://www.vcbacked.co/company/newleaf-symbiotics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated